Vivani Medical Inc. (VANI)
NASDAQ: VANI
· Real-Time Price · USD
1.25
0.01 (0.81%)
At close: Aug 19, 2025, 10:15 AM
Company Description
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.
It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
The company is headquartered in Emeryville, California.
Vivani Medical Inc.
| Country | United States |
| IPO Date | Nov 19, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Adam Mendelsohn |
Contact Details
Address: 5858 Horton Street Alameda, California United States | |
| Website | https://www.vivani.com |
Stock Details
| Ticker Symbol | VANI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001266806 |
| CUSIP Number | 92854B109 |
| ISIN Number | US92854B1098 |
| Employer ID | 00-0000000 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Adam Mendelsohn Ph.D. | Co-Founder, Chief Executive Officer & Director |
| Brigid Ann Makes M.B.A. | Chief Financial Officer and Principal Financial & Accounting Officer |
| Donald Dwyer M.B.A. | Chief Business Officer & Corporate Secretary |
| Dr. Lisa E. Porter M.D. | Chief Medical Officer |
| Truc Le M.B.A. | Chief Operations Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2025 | 10-Q | Quarterly Report |
| Aug 13, 2025 | 8-K | Current Report |
| Aug 05, 2025 | 8-K | Current Report |
| Jun 26, 2025 | 4 | Filing |
| Jun 26, 2025 | 4 | Filing |
| Jun 26, 2025 | 4 | Filing |
| Jun 26, 2025 | 4 | Filing |
| Jun 26, 2025 | 4 | Filing |
| Jun 25, 2025 | 8-K | Current Report |
| Jun 17, 2025 | 4 | Filing |